{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T19:05:35Z","timestamp":1783105535025,"version":"3.54.6"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T00:00:00Z","timestamp":1585785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006315","name":"ReumaNederland","doi-asserted-by":"publisher","award":["LLP-29"],"award-info":[{"award-number":["LLP-29"]}],"id":[{"id":"10.13039\/501100006315","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00420","type":"journal-article","created":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T04:35:08Z","timestamp":1585802108000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Lack of Conventional Acinar Cells in Parotid Salivary Gland of Patient Taking an Anti-PD-L1 Immune Checkpoint Inhibitor"],"prefix":"10.3389","volume":"10","author":[{"given":"Sarah","family":"Pringle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"van der Vegt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"van Bakelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Jeroen N.","family":"Hiltermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred K. L.","family":"Spijkervet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Vissink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans G. M.","family":"Kroese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrika","family":"Bootsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejca.2015.11.016","article-title":"Immune-related adverse events with immune checkpoint blockade: a comprehensive review","volume":"54","author":"Michot","year":"2016","journal-title":"Eur J Cancer."},{"key":"B2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/annrheumdis-2016-209595","article-title":"Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab","volume":"76","author":"Cappelli","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1634\/theoncologist.2018-0823","article-title":"Sicca syndrome associated with immune checkpoint inhibitor therapy","volume":"24","author":"Warner","year":"2019","journal-title":"Oncologist."},{"key":"B4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.autrev.2018.01.010","article-title":"Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitors","volume":"17","author":"Tocut","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1634\/theoncologist.2019-0467","article-title":"Sicca syndrome induced by immune checkpoint inhibitor therapy: optimal management still pending","volume":"25","author":"Ortiz Brugu\u00e9s","year":"2020","journal-title":"Oncologist"},{"key":"B6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.devcel.2015.02.013","article-title":"Salivary gland homeostasis is maintained through acinar cell self-duplication","volume":"33","author":"Aure","year":"2015","journal-title":"Dev Cell."},{"key":"B7","doi-asserted-by":"publisher","first-page":"166363","DOI":"10.1242\/dev.166363","article-title":"Diverse progenitor cells preserve salivary gland ductal architecture after radiation induced damage","volume":"145","author":"May","year":"2018","journal-title":"Development"},{"key":"B8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/art.40659","article-title":"Salivary gland stem cells age prematurely in primary Sj\u00f6gren's syndrome","volume":"71","author":"Pringle","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.celrep.2018.07.016","article-title":"Limited regeneration of adult salivary glands after severe injury involves cellular plasticity","volume":"24","author":"Weng","year":"2018","journal-title":"Cell Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1158\/1078-0432.CCR-14-2468","article-title":"Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma","volume":"21","author":"Gibney","year":"2015","journal-title":"Clin Cancer Res."},{"key":"B11","first-page":"114","article-title":"Sicca\/Sj\u00f6gren's syndrome triggered by PD-1\/PD-L1 checkpoint inhibitors","volume":"37","author":"Ramos-Casals","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/13543784.2019.1631796","article-title":"Small-molecule inhibitors and the salivary gland epithelium in Sj\u00f6gren's syndrome","volume":"28","author":"Pringle","year":"2019","journal-title":"Expert Opin Investig Drugs"},{"key":"B13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1586\/1744666X.2014.891439","article-title":"B-cell hyperactivity in primary Sj\u00f6gren's syndrome","volume":"10","author":"Kroese","year":"2014","journal-title":"Expert Rev Clin Immunol."},{"key":"B14","first-page":"42","article-title":"Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sj\u00f6gren's syndrome patients","volume":"118","author":"van Ginkel","year":"2019","journal-title":"Clin Exp Rheumatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1136\/annrheumdis-2017-212331","article-title":"The parotid gland connection: ultrasound and biopsies in primary Sj\u00f6gren's syndrome","volume":"77","author":"Mossel","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1136\/annrheumdis-2017-211250","article-title":"Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sj\u00f6gren's syndrome","volume":"76","author":"Mossel","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24017","article-title":"Incorporation of salivary gland ultrasonography into the ACR-EULAR criteria for primary Sj\u00f6gren's syndrome","author":"van Nimwegen","year":"2019","journal-title":"Arthritis Care Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.rdc.2016.03.007","article-title":"Parotid gland biopsy, the alternative way to diagnose Sj\u00f6gren syndrome","volume":"42","author":"Spijkervet","year":"2016","journal-title":"Rheum Dis Clin North Am."},{"key":"B21","doi-asserted-by":"publisher","first-page":"212164","DOI":"10.1136\/annrheumdis-2017-212164","article-title":"Standardisation of the detection of germinal centres in salivary gland biopsies of patients with primary Sj\u00f6gren's syndrome is needed to assess their clinical relevance","volume":"22","author":"Haacke","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3109\/14397595.2015.1083146","article-title":"Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sj\u00f6gren's syndrome including neuromyelitis optica complicated patients","volume":"26","author":"Yoshimura","year":"2016","journal-title":"Mod Rheumatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.7162\/S1809-97772013000200008","article-title":"Effect of fractionated radiotherapy on the parotid gland: an experimental study in Brazilian minipigs","volume":"17","author":"Stramandinoli-Zanicotti","year":"2013","journal-title":"Int Arch Otorhinolaryngol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/ard.2004.033837","article-title":"Basal lamina disorganisation of the acini and ducts of labial salivary glands from patients with Sj\u00f6gren's syndrome: association with mononuclear cell infiltration","volume":"65","author":"Molina","year":"2006","journal-title":"Ann Rheum Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41408-019-0185-9","article-title":"Reverse signaling via PD-L1 supports malignant cell growth and survival in classical Hodgkin lymphoma","volume":"9","author":"Jalali","year":"2019","journal-title":"Blood Cancer J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/cancers11050624","article-title":"Immune checkpoint ligand reverse signaling: looking back to go forward in cancer therapy","volume":"11","author":"Lecis","year":"2019","journal-title":"Cancers"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00420\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T04:35:12Z","timestamp":1585802112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00420\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,2]]},"references-count":26,"alternative-id":["10.3389\/fonc.2020.00420"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00420","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,2]]},"article-number":"420"}}